Introduction
Nanogels, nanoscale hydrogel particles formed by chemically or physically crosslinked polymer chains, have attracted much attention in recent years for their high drug-carrying capacity, environmental responsiveness, and stability in aqueous media.
1,2 While they have been employed in several studies to deliver small therapeutic agents 3, 4 and biomacromolecules, 5, 6 their advantages for use as biomedical imaging agents, such as water access throughout the particle 7 and protection of the payload, have not been thoroughly explored.
Metals have many applications in medicine, including as contrast agents in multiple biomedical imaging modalities (PET, MRI), and as radiotherapeutics. Incorporating metals into nanogels can impart properties useful in medicine. However, no versatile and reproducible chemistry yet exists to incorporate metals into nanogels in a stable manner that is of clinical relevance. Clinical development of high-contrast magnetic resonance imaging (MRI) agents is an important area of investigation that relies on Gd 3+ chelates. Gd-based MRI agents could allow tissue-or disease-specic imaging using this accurate diagnostic imaging modality capable of providing submillimeter spatial resolution and unrivalled so tissue contrast.
8-10
Previously employed strategies combining Gd 3+ chelates with nanogels include the encapsulation of small contrast agent molecules inside an electrostatically crosslinked polymer 11 or the post-polymerization functionalization of nanogels with contrast agents, 12 both of which enhance relaxivity by slowing the chelates' molecular tumbling rate.
14,15 These designs follow the example of numerous other groups that have attached Gd 3+ chelates to high molecular weight macromolecules, including dendrimers, [13] [14] [15] [16] 24, 25 or proteins through covalent [26] [27] [28] [29] [30] or non-covalent interactions. [31] [32] [33] By using gadolinium complexes directly as crosslinkers, the whole nanoparticle incorporates contrast agents, in contrast to post-functionalized nanoparticles or gadolinium-based inorganic nanoparticles, in which only surface gadolinium can relax water protons. This strategy also allows us to keep the nanogel surface available for further functionalization, for example with targeting agents. We also hypothesized that incorporating the contrast agent into a macromolecular network as a crosslinker would further increase rigidity and thus relaxivity. Importantly, metal chelating crosslinkers can be used with a variety of metals, such as radioisotopes for positron emission tomography or cancer radiotherapy.
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The design of the target crosslinker 1 (Fig. 1 ) was based on diethylenetriaminepentacetatic acid (DTPA) and was rst selected because of its ease of synthesis. The second crosslinker structures were selected for their potential for greater safety in vivo; it has been reported that cyclic structures are more stable than DTPA, 35 better protecting and binding the central Gd 3+ . A cyclic crosslinker would thus decrease toxicity, which is related to the risk of nephrogenic systemic brosis (NSF) via transmetallation with endogenous ions such as zinc or copper and resulting release of free Gd
3+
. Thus we decided to design two other crosslinkers based on the 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) chelating agent. The design of these macrocyclic crosslinkers 2 and 3 ( Fig. 1 ) was based on a DOTA unit bearing a bisacrylamide moiety. The DOTA macrocycle is C-substituted in order to avoid any interference with the coordination site of the ligand. This choice is based on previous observations that chelates with a hydration number greater than one are relatively unstable; q ¼ 1 for all commercial agents. Therefore, though other designs allow a greater hydration number, which yields higher relaxivity, [36] [37] [38] [39] we chose C substitution to minimize dechelation. Furthermore, incorporating the chelate into a nanogel both enhances relaxivity by limiting movement and improves Gd 3+ chelating stability by reducing access of other metal ions. To the best of our knowledge, this work is the rst example of nanogels incorporating DOTA chelating agents as crosslinkers. Herein we report the development of model polyacrylamide (PAA)-based nanogels incorporating DTPA-and DOTA-based crosslinkers. Given the size of these nanogels (<100 nm), which should allow prolonged circulation, these chelators should be useful in the development of biodegradable nanoparticles for a number of biomedical applications involving metals.
Results and discussion

Synthesis of the crosslinkers
Crosslinker 1 was obtained in a one-step synthesis by reacting commercially available DTPA-bisanhydride with N-(3-aminopropyl) methacrylamide hydrochloride in the presence of triethylamine. The adopted strategy for the synthesis of the two DOTA-based crosslinkers 2 and 3 was convergent (Scheme 1). The C-substituted protected DOTA derivatives 5 and 7 were prepared in 4 and 5 steps, respectively, according to a procedure reported in the literature. 40 In parallel, the bisacrylamide derivatives 4 and 9 were synthesized in one or two steps from the commercial 3,5-diaminobenzoic acid and 3,5-dinitroiodobenzene, respectively. The latter was rst reduced with tin chloride to give the 3,5-diaminoiodobenzene 8. The two diamino compounds were acrylated by using acryloyl chloride under Schotten-Baumann conditions (two-phase solvent system) to give 4 and 9. These bisacrylamide derivatives were then coupled with the protected DOTA derivatives 5 and 7 via coupling reactions: an ester coupling reaction to form the protected crosslinker 6, and a Sonogashira cross-coupling reaction to form the protected crosslinker 10. Finally, the two target crosslinkers 2 and 3 were obtained aer TFA deprotection of the tert-butyl ester functions of 6 and 10.
Nanogel preparation
The crosslinkers 1, 2 and 3 were chelated using GdCl 3 and heating at 40 C at pH 6. Excess gadolinium was removed by adding the chelating resin Chelex-100 and ltering the solution.
The gadolinium complexes 1Gd(III), 2Gd(III) and 3Gd(III) were then used to prepare polyacrylamide-based nanogels PAA/ 1Gd(III), PAA/2Gd(III) and PAA/3Gd(III) through an inverse emulsion process using ammonium persulfate (APS) as the initiator and by adding tetramethylethylenediamine (TMEDA) to control the radical polymerization rate (Fig. 2) . 
Nanogel characterization
The nanogels obtained were characterized by dynamic light scattering (DLS) in order to evaluate their hydrodynamic volume and size distribution (Fig. 3) . PAA/1Gd(III) had an average size of 65 nm with a polydispersity index (PDI) of 0.16, and PAA/2Gd(III) and PAA/3Gd(III) were on average 54 nm and 85 nm in diameter with PDI values of 0.25 and 0.39, respectively. Nanogels were then visualized (Fig. 4) by transmission electron microscopy (TEM). Spherical nanogel particles with smaller sizes were observed, which is in accordance with the hydrodynamic sizes measured by DLS. Spherical voids seen on the TEM microphotographs are most likely generated by water escaping from the nanogel upon placement under vacuum and irradiation by the electron beam.
To evaluate the effect of nanogels on cell viability, murine macrophages were incubated with PAA/1Gd(III), PAA/2Gd(III) and PAA/3Gd(III) at various concentrations, and cytotoxicity was measured by MTT assay (Fig. S1 †) . From the MTT assay results, it appears that PAA/1Gd(III), PAA/2Gd(III) and PAA/3Gd(III) are well tolerated by the cells at concentrations up to 100 mg ml À1 .
Relaxivity studies
In order to test our central hypothesis, the relaxivity values of all Gd 3+ complexes (crosslinkers alone and nanogels incorporating crosslinkers 1, 2, and 3) were calculated. Proton NMRD proles were also recorded at 37 C and analyzed using the classical inner sphere and outer sphere theories (Fig. 5) . As expected from its larger molecular weight, the complexed crosslinker 1Gd(III) has a larger relaxivity than MagnevistÒ. The larger value of the tted water residence time agrees with previous results showing that replacement of carboxylic groups with amides reduces the water exchange rate. 1, 41 The incorporation of the complexed crosslinker 1Gd(III) into nanogels resulted in an increase of relaxivity from 4.8 AE 0.2 mM À1 s À1 for the crosslinker alone to 9.7 AE 0.5 mM À1 s À1 for the corresponding PAA nanogel at 60 MHz and 37 C. This corresponds to a 2-fold improvement in relaxivity over MagnevistÒ aer incorporation of the DTPA crosslinker into nanogels. The decrease in mobility of the Gd complex in the nanogels was further conrmed by the NMRD proles showing a "hump" between 10 and 100 MHz (Fig. 5) . The r 1 increase is lower than expected for PAA/1Gd(III) due to the slow water exchange rate resulting from the amide chelating groups. As expected, since the substitution of the DOTA macrocycle would slow molecular tumbling, our complexed crosslinkers 2Gd(III) and 3Gd(III) exhibited higher relaxivities than DotaremÒ, of 4.3 AE 0.2 mM À1 s À1 and 5.0 AE 0.3 mM À1 s
À1
, respectively, at 60 MHz. The slightly higher relaxivity of 3Gd(III) compared to 2Gd(III) could be explained by its higher rotational correlation time s R (Table S1 †) corresponding to a slightly slower tumbling frequency. As anticipated, the NMRD prole shows that the s M , s SO and s V values are quite similar for both complexes and comparable to those of Gd-DOTA (Table S1 †). The relaxivity of nanogels incorporating 2Gd(III) and 3Gd(III) was greater than that of the complexed crosslinkers alone, at 17.6 AE 0.9 mM À1 s À1 and 14.8 AE 0.7 mM À1 s
, respectively. This 3 to 4-fold increase in relaxivity can be explained by the relative rigidity of the system aer crosslinking. These r 1 values are 5.1 to 6.1-fold improvements over DotaremÒ. While these enhancements are limited by the slower water exchange rate in the nanogels, the faster water exchange rate as compared to PAA/1Gd(III) results in a faster relaxation rate of these two DOTA-based nanogels.
Based on the density of our nanogels (1.016 g mL À1 ; see ESI †), the Gd concentration, and the average nanoparticle volume (calculated from the nanoparticle size measured by DLS), we calculated the number of Gd 3+ per particle to be 134.
This value allowed us to obtain the relaxivity per particle, which was 2352 mM À1 s À1 in the case of PAA/2Gd(III).
Although the tumbling frequency of the crosslinker in the nanogel is reduced because the attachment of the bismethacrylamide or bisacrylamide linkers restricts each chelate's rotation, the motions of the linkers are still rapid. This internal exibility becomes the limiting factor for further reductions in tumbling frequency and increases in relaxivity.
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This also explains the similar r 1 among nanogels with different crosslinking densities (see Fig. S2 †) . These nanogels have an overall denser structure at a higher crosslinking density; however, locally, the exibility of the linkers remains high. As a result, increasing crosslinking density has no signicant effect on r 1 (Fig. 5) .
To be clinically translatable, an MRI contrast agent should minimize release of toxic Gd, which occurs mainly through transmetallation of Gd with endogenous metal ions. 7, 43, 44 This released Gd 3+ can accumulate in the body, sometimes causing nephrogenic systemic brosis, especially in patients with reduced kidney function. 43, 44 Among the endogenous ions, Zn 2+ is most likely to displace Gd 3+ because of its relatively high concentration in vivo, high affinity to metal chelates, and similar radius to that of Gd 3+ . The stability of all the chelated crosslinkers and their corresponding nanogels toward transmetallation was evaluated by monitoring their paramagnetic longitudinal relaxation rate 1/T 1 over time in the presence of other metal ions (Fig. 6 ). Specically, we followed a method described in the literature, 44, 45 incubating our complexes at a Gd 3+ concentration of 2.5 mM with 2.5 mM zinc chloride in phosphate buffer ([PO 4   3À ] ¼ 25 mM) at 37 C. The concentration of Zn 2+ used is at least twenty times greater than in plasma; this high concentration makes any difference in transmetallation apparent more rapidly. Upon transmetallation of Gd 3+ with Zn 2+ , free Gd 3+ ions are released and an insoluble Gd(PO 4 ) complex is formed, preventing rechelation of Gd 3+ to DOTA. As a control, complexes were incubated without zinc chloride. For all three DTPA-based contrast agents, r 1 decreases over time, indicating transmetallation with Zn 2+ . However, transmetallation in the nanogel is much slower than that of MagnevistÒ and 1Gd(III), taking three to ve times as long to decrease to 80% of initial r 1 , respectively. This indicates that our nanogel PAA/1Gd(III) has a slower rate of transmetallation than the other two chelates. Aer 66 h, the nanogel's r 1 decreased by 23%, compared to $40% and $80% decreases for MagnevistÒ and 1Gd(III), respectively, suggesting that PAA/1Gd(III) transmetallates to a lesser extent. This stability likely results from greater structural rigidity 35 and reduced Zn 2+ accessibility to chelating sites. In a control experiment without Zn 2+ , r 1 did not change appreciably for any of the three contrast agents (see Fig. S3 †) . These results suggest that our nanogel, compared to MagnevistÒ or 1Gd(III), is more inert against dechelation and is potentially a safer MRI contrast agent. DOTA-based crosslinkers 2 and 3 and their corresponding nanogels all appear highly stable, with 2Gd(III) and 3Gd(III) losing less than 5% of Gd 3+ over three days. The nanogels' relaxation rate did not decrease at all and instead increased slightly, likely because of evaporation of buffer during the three days of incubation. These results conrm that the incorporation of the crosslinkers into nanogels leads to enhanced stability, which is maximal in the case of the DOTA-based nanogels. We also examined the contrast provided by all our Gd(III) complexes (1Gd(III), 2Gd(III), 3Gd(III) and their corresponding nanogels PAA/1Gd(III), PAA/2Gd(III), PAA/3Gd(III)) by phantom imaging at 7 T, with MagnevistÒ and DotaremÒ as controls (see Fig. S4 †) . At identical gadolinium concentrations, better contrast was obtained with the nanogels compared to either chelated crosslinkers alone or the clinical contrast agents. Therefore, by using such systems, smaller doses of gadolinium would provide similar contrast to that obtained with clinically used contrast agents.
Conclusions
In this article, we have shown that incorporation of gadolinium chelate crosslinkers into nanogels leads to a signicant (3 to 4-fold) increase in relaxivity. 
